These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Increased HLA-DR and CD44 antigen expression in the gut: evidence of extraarticular immunological activity in rheumatoid arthritis. Abuzakouk M; Feighery C; Kelleher D; O'Briain DS; Jones E; Weir D; Casey E; O'Farrelly C J Rheumatol; 1999 Sep; 26(9):1869-76. PubMed ID: 10493664 [TBL] [Abstract][Full Text] [Related]
23. gamma delta-Lymphocytes in the peripheral blood of patients with rheumatoid arthritis--correlation with clinical and laboratory parameters of the disease and with the treatment used. Kowal-Bielecka O; Mróz R; Bernacka K; Kowal E; Sierakowski S Rocz Akad Med Bialymst; 2001; 46():170-81. PubMed ID: 11780560 [TBL] [Abstract][Full Text] [Related]
24. Osteoprotegerin and receptor activator of nuclear factor-kappaB ligand mRNA expression in patients with rheumatoid arthritis and healthy controls. Vanderborght A; Linsen L; Thewissen M; Geusens P; Raus J; Stinissen P J Rheumatol; 2004 Aug; 31(8):1483-90. PubMed ID: 15290725 [TBL] [Abstract][Full Text] [Related]
25. High avidity state of leukocyte function-associated antigen-1 on rheumatoid synovial fluid T lymphocytes. Yokota A; Murata N; Saiki O; Shimizu M; Springer TA; Kishimoto T J Immunol; 1995 Oct; 155(8):4118-24. PubMed ID: 7561125 [TBL] [Abstract][Full Text] [Related]
26. Increased nuclear factor-kappaB activation in peripheral blood monocytes of patients with rheumatoid arthritis is mediated primarily by tumor necrosis factor-alpha. Dichamp I; Bourgeois A; Dirand C; Herbein G; Wendling D J Rheumatol; 2007 Oct; 34(10):1976-83. PubMed ID: 17896809 [TBL] [Abstract][Full Text] [Related]
27. Impaired activation-induced telomerase activity in PBMC of early but not chronic rheumatoid arthritis patients. Thewissen M; Linsen L; Geusens P; Raus J; Stinissen P Immunol Lett; 2005 Sep; 100(2):205-10. PubMed ID: 16154497 [TBL] [Abstract][Full Text] [Related]
29. Expression of activation-induced, T cell-derived, and chemokine-related cytokine/lymphotactin and its functional role in rheumatoid arthritis. Blaschke S; Middel P; Dorner BG; Blaschke V; Hummel KM; Kroczek RA; Reich K; Benoehr P; Koziolek M; Müller GA Arthritis Rheum; 2003 Jul; 48(7):1858-72. PubMed ID: 12847680 [TBL] [Abstract][Full Text] [Related]
30. [Neopterin: laboratory marker of cellular immunity activation in rheumatoid arthritis]. Nasonov EL; Samsonov MIu; Chichasova NV; Imametdinova GR; Nikiforova EL; Aleksandrova EN; Ilich-Stoyanovich O; Fux D; Vaxter H Ter Arkh; 1998; 70(5):28-31. PubMed ID: 9644738 [TBL] [Abstract][Full Text] [Related]
31. Evaluation of lymphocyte populations and their mitogenic activity in relation to serum copper and immunoglobulin levels in rheumatoid arthritis. Attia WM; Clark HW; Brown TM Ann Allergy; 1981 Aug; 47(2):99-103. PubMed ID: 7258747 [TBL] [Abstract][Full Text] [Related]
32. Autoantibodies against Tmu and B lymphocytes in patients with rheumatoid arthritis. Meijer CJ; Cnossen J; Lafeber GJ; Damsteeg MJ; Cats A Clin Exp Immunol; 1982 Feb; 47(2):368-80. PubMed ID: 6978781 [TBL] [Abstract][Full Text] [Related]
34. Circulating activated lymphocytes in rheumatoid arthritis: a marker of synovial inflammation. Papadimitriou GM; Bacon PA; Hall ND J Rheumatol; 1982; 9(2):217-23. PubMed ID: 7097680 [TBL] [Abstract][Full Text] [Related]
35. [Lymphocyte blast transformation according to the clinical variant of rheumatoid arthritis]. Popova L; Pekhlivanov D; Matev M; Apostolov P; Sheĭtanov I Vutr Boles; 1980; 19(2):39-43. PubMed ID: 6966867 [TBL] [Abstract][Full Text] [Related]
36. Enhanced T cell proliferative response to type II collagen and synthetic peptide CII (255-274) in patients with rheumatoid arthritis. Kim HY; Kim WU; Cho ML; Lee SK; Youn J; Kim SI; Yoo WH; Park JH; Min JK; Lee SH; Park SH; Cho CS Arthritis Rheum; 1999 Oct; 42(10):2085-93. PubMed ID: 10524679 [TBL] [Abstract][Full Text] [Related]
37. Anti-CCP2 is an adjunct to, not a surrogate for, rheumatoid factor in the diagnosis of rheumatoid arthritis: diagnostic utility of anti-CCP2 antibodies in Egyptian patients with rheumatoid arthritis. Abdel-Nasser AM; Mahmoud MH; El Mansoury TM; Osman AM Scand J Rheumatol; 2008; 37(5):329-36. PubMed ID: 18666028 [TBL] [Abstract][Full Text] [Related]
38. Immunomodulation by isoprinosine: effects on in vitro immune functions of lymphocytes from humans with autoimmune diseases. Nakamura T; Miyasaka N; Pope RM; Talal N; Russell IJ Clin Exp Immunol; 1983 Apr; 52(1):67-74. PubMed ID: 6190598 [TBL] [Abstract][Full Text] [Related]
39. p205 is a major target of autoreactive T cells in rheumatoid arthritis. Bläss S; Schumann F; Hain NA; Engel JM; Stuhlmüller B; Burmester GR Arthritis Rheum; 1999 May; 42(5):971-80. PubMed ID: 10323453 [TBL] [Abstract][Full Text] [Related]
40. Alterations of the synovial T cell repertoire in anti-citrullinated protein antibody-positive rheumatoid arthritis. Cantaert T; Brouard S; Thurlings RM; Pallier A; Salinas GF; Braud C; Klarenbeek PL; de Vries N; Zhang Y; Soulillou JP; Tak PP; Baeten D Arthritis Rheum; 2009 Jul; 60(7):1944-56. PubMed ID: 19565497 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]